On the use of sibling recurrence risks to select environmental factors liable to interact with genetic risk factors.: GxE interaction and sibling recurrence risk by Kazma, Rémi et al.
On the use of sibling recurrence risks to select
environmental factors liable to interact with genetic risk
factors.
Re´mi Kazma, Catherine Bona¨ıti-Pellie´, Jill Norris, Emmanuelle Ge´nin
To cite this version:
Re´mi Kazma, Catherine Bona¨ıti-Pellie´, Jill Norris, Emmanuelle Ge´nin. On the use of sib-
ling recurrence risks to select environmental factors liable to interact with genetic risk fac-
tors.: GxE interaction and sibling recurrence risk. Eur J Hum Genet, 2010, 18 (1), pp.88-94.
<10.1038/ejhg.2009.119>. <inserm-00446027>
HAL Id: inserm-00446027
http://www.hal.inserm.fr/inserm-00446027
Submitted on 11 Jan 2010
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
 1 
On the use of sibling recurrence risks to select environmental factors 
liable to interact with genetic risk factors 
 
 
Rémi Kazma
*,1,2
, Catherine Bonaïti-Pellié
3,1
, Jill M. Norris
4
, Emmanuelle Génin
2,5
 
 
 
 
 
1
 Univ. Paris-Sud, Faculté de Médecine, Le Kremlin Bicêtre, France 
2
 Inserm, UMR-S946, Fondation Jean Dausset – CEPH, Paris, France 
3
 Inserm, UMR-S535, Villejuif, France 
4
 Department of Preventive Medicine and Biometrics, University of Colorado Denver, 
Denver, Colorado, USA 
5 Univ. Paris-Diderot, Paris, France  
* Correspondence: R Kazma, Inserm UMR-S946, Fondation Jean Dausset – CEPH, 27 
rue Juliette Dodu, Paris 75010, France. Tel: +33153725027; Fax: +33153725049; E-
mail: remi.kazma@inserm.fr  
 
 
 
 
Running title: GxE interaction and sibling recurrence risk 
 
 2 
Abstract 
Gene-environment interactions are likely to be involved in the susceptibility to 
multifactorial diseases but are difficult to detect. Available methods usually concentrate 
on some particular genetic and environmental factors. In this paper, we propose a new 
method to determine whether or not a given exposure is susceptible to interact with 
unknown genetic factors. Rather than focusing on a specific genetic factor, the degree of 
familial aggregation is used as a surrogate for genetic factors. A test comparing the 
recurrence risks in sibs according to the exposure of indexes is proposed and its power 
is studied for varying values of model parameters. The Exposed versus Unexposed 
Recurrence Analysis (EURECA) is valuable for common diseases with moderate 
familial aggregation, only when the role of exposure has been clearly outlined. 
Interestingly, accounting for a sibling correlation for the exposure increases the power 
of EURECA. An application on a sample ascertained through one index affected with 
type 2 diabetes is presented where gene-environment interactions involving obesity and 
physical inactivity are investigated. Association of obesity with type 2 diabetes is 
clearly evidenced and a potential interaction involving this factor is suggested in 
Hispanics (p=0.045), whereas a clear gene-environment interaction is evidenced 
involving physical inactivity only in Non-Hispanic Whites (p=0.028). The proposed 
method might be of particular interest prior to genetic studies to help determine the 
environmental risk factors that will need to be accounted for to increase the power to 
detect genetic risk factors and to select the most appropriate samples to genotype.  
 
Keywords: diabetes mellitus, type 2; epidemiologic research design; familial 
aggregation; genetic predisposition to disease; environmental exposure. 
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Introduction 
If gene-environment (GxE) interactions are expected to play an important role in 
multifactorial disease susceptibility
1
 genetic and environmental factors are most often 
evaluated independently rather than jointly. Joint analysis and GxE interaction testing is 
usually performed in a second step once the observed effects of each factor has been 
evidenced
2-4
. Using such a strategy, we are likely to miss important genetic or 
environmental factors which effects could only be detected when accounting for the 
other factor
5,6
. This was clearly evidenced in the study by Selinger-Leneman et al.
6
 
where it was shown that the power to detect a genetic risk factor interacting with an 
environmental risk factor might be considerably reduced when the environmental 
exposure of individuals is not accounted for. However, this was very dependent on the 
environmental risk factor prevalence, on its effect on the disease and on its interaction 
with the genetic factor. In some situations, accounting for the environmental exposure 
was even detrimental in terms of power. This first study called for the need to develop 
methods to select environmental factors that might be involved in GxE interaction and 
should therefore be accounted for in genetic studies.  
The problem of selecting environmental exposures to account for in genetic 
studies becomes even more crucial when performing genome-wide association studies 
with hundreds of thousands of markers. Indeed, in this context, for each exposure to 
study, there is such a huge number of tests to perform that one wants to make sure that 
only relevant exposures are accounted for. The development of methods to select these 
relevant environmental factors will probably be the first step in order to test for GxE 
interactions at the genome-wide levels. 
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In their previous work, Selinger-Leneman et al.
6
 have shown that selecting 
environmental factors based solely on their observed effects is not an efficient strategy 
and it might be useful to find a statistical tool to determine if they are likely to interact 
with genetic risk factors. This, however, should be done prior to the genetic analysis and 
thus involves the use of methods that do not require genotyping data. One such method 
was proposed by Purcell
7
 for twin data and relies on variance component modeling. 
Apart from the fact that it requires twin data, the method also requires exposure status 
of both sibs which is not always easy to obtain. Our proposed method also uses familial 
aggregation of the disease as a surrogate for the genetic factors but exposure in indexes 
only. Indeed, as suggested by Stücker et al.
8
, familial aggregation of disease would be 
different for exposed and unexposed indexes if the environmental factor studied is 
involved in GxE interaction. A rational for this property is that, in presence of GxE 
interaction, exposed indexes have not the same distribution of genotypes as unexposed 
indexes. Their sibs will consequently have a different probability of having the disease 
from those of unexposed indexes. 
In this paper, we used this idea of difference in sibling recurrence risks based on 
index’s exposure to propose a test aimed at selecting environmental factors that are 
prone to interact with the genetic component of a multifactorial disease and propose a 
simple statistical test. We study the statistical properties of this test under different 
models and apply it on a type 2 diabetes (T2D) sample. 
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Materials and Methods 
To evidence a difference in the recurrence risk for siblings of exposed and 
unexposed individuals, we need data on a sample of sib pairs ascertained through an 
affected index (sib 1). The variable of interest is the affection status of the other sib (sib 
2) and the explicative variable is the exposure status of sib 1. The data can be presented 
in a contingency table such as table 1.  
 
Odds Ratio of Recurrence and Exposed versus Unexposed Recurrence Analysis 
Let KS be the sibling recurrence risk defined as the probability of sib 2 being 
affected given sib 1 is affected
9
 and KSE and KSĒ these risks when sib 1 is exposed and 
unexposed respectively to a given environmental factor E. To measure the difference 
between these two stratified risks, an Odds Ratio of Recurrence (ORR) can be calculated 
by analogy with an Odds Ratio (OR): 
 
 
SEES
ESSE
KK
KK
ORR



1
1
     (1) 
Deriving the above recurrence risks as a function of observed numbers in the 
contingency table (table 1), the ORR can be expressed as:  
bc
ad
ORR   
In contrast to the OR of an environmental factor where exposure and disease 
statuses are measured in the same individual, in the ORR, exposure is measured in the 
affected index and the disease status is measured in the sib. 
 In the presence of a GxE interaction involving environmental factor E, we 
expect the ORR to be different from 1. To test for "ORR = 1", we propose to perform a 1 
degree of freedom (df) chi-square test on the contingency table crossing sib 1’s 
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exposure with sib 2’s affection status (table 1) or the asymptotically similar Wald test 
based on the logistic regression parameter estimate and its variance. This test will be 
referred to as the Exposed versus Unexposed Recurrence Analysis (EURECA) test. 
 
Properties of the ORR and of the EURECA test under different models 
In order to study the behavior of the ORR and the statistical properties of 
EURECA, we considered a model of interaction involving a single gene (G) and a single 
environmental factor (E) even though the method practically only uses environmental 
information. We computed the expected numbers in each cell of the contingency table 
and derived the different recurrence risks (table 1) under the different models of gene-
environment interaction defined by the parameters presented in table 2. A disease D 
with population prevalence fD is considered. It is assumed that D is causally associated 
only with an environmental factor E and a genetic factor G.  
The E factor is dichotomous with population frequency fE and a main effect size 
on D measured by the exposure relative risk, RRE. To model the possibility for a 
familial clustering of E, as in Khoury et al.
10
, we define the conditional probability of 
sib 2 being exposed given the exposure status of sib 1 as: 
P(sib 2 E+ | Y1) = (1 – CE) × fE + CE × Y1   (2) 
where Y1 is a dummy variable that takes the value 1 when sib 1 is exposed and 0 
otherwise, and CE is the environmental correlation between the sibs. Thus, when CE = 0, 
sib 2’s exposure status is independent from sib 1’s exposure status and its probability is 
always equal to the prevalence of E in the general population, fE. When CE = 1, 
correlation between sibs for exposure is complete and sib 2’s exposure probability is 
equal to 1 when sib 1 is exposed and 0 when sib 1 is unexposed. 
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The G factor corresponds to a predisposing genetic factor localized on an 
autosomal biallelic genetic locus. The allele that confers predisposition to disease is 
noted A and has a population frequency of q, whereas the other allele a has a population 
frequency of 1–q. Frequencies of the different possible genotypes (AA, Aa and aa) are 
supposed to follow Hardy-Weinberg proportions in the population (i.e., q
2
, 2q(1–q), (1–
q)
2
, respectively). The main effect of the G factor is measured by the genotypic relative 
risk (RRG) which corresponds to the ratio of the disease risk in carriers of the 
predisposing genotype(s) to the risk in non-carriers of the predisposing genotype(s) 
among unexposed individuals. In all situations, we compared dominant and recessive 
genetic models for a given frequency fG of predisposing genotype(s), with fG = q
2
 under 
a recessive model and fG = q
2
+2q(1–q) under a dominant model. 
Let B designate the baseline risk i.e. the probability of disease for a non-carrier 
and unexposed individual. The interaction between E and G is measured by an 
interaction coefficient I, which corresponds to a departure from a multiplicative model 
when both E and G are present. In the absence of interaction, the risk of an individual 
exposed and carrier of the predisposing genotype is the product of B, RRE and RRG. In 
the presence of interaction, this risk is multiplied by the interaction coefficient I (table 
2). The conditional risks of disease given genotype and exposure status and the numbers 
of the contingency table cells were derived using the ITO matrix method of Li and 
Sacks
11
 modified in order to account for the environmental factor. Computations were 
done with the Maple 10 software
12
 and explanations are given in the Supplementary 
materials. 
Type I error and power of the EURECA test were asymptotically estimated 
considering a sample of 1000 sib-pairs by use of 1 df non-central chi-square 
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distributions. Alternatively, we calculated the required number of sib-pairs to reach a 
power of 0.80 with a type I error rate of 0.05. 
 
Application to type 2 diabetes 
The Gene ENvironment Interactions (GENI) study
13
 collected phenotypic and 
environmental data of type 2 diabetic subjects and their families living in the San Luis 
Valley and the Denver metropolitan area in Colorado (USA). Among 452 pedigrees 
(3090 nuclear families) ascertained through one index sib affected with T2D, we 
extracted 2699 index-sib pairs for which data was available in the index for at least one 
of the two studied exposures: obesity and physical inactivity. Of those pairs, 1734 were 
Hispanics (H) and 965 were Non-Hispanic Whites (NHW). Subjects previously 
diagnosed by a physician as having T2D and treated with oral hypoglycemic agents or 
insulin were considered affected. For subjects that did not report having T2D or subjects 
untreated for T2D, diabetic status was determined by an oral glucose tolerance test 
using American Diabetes Association criteria (1997). For diabetic subjects, self reported 
body mass index (BMI) at the time of diagnosis was used. BMI was calculated at 
recruitment time for other subjects. Individuals having a BMI value exceeding 30 kg/m
2
 
were classified as obese. Physical activity assessment was done once during the study 
using a previously validated questionnaire self-administered by the subjects
14
. Energy 
expenditure was assessed as metabolic equivalent task (MET) units. The MET is the 
ratio of the metabolic rate during exercise to the metabolic rate at rest
15
. The average 
METs per week (prior to the diagnosis of T2D for affected individuals) was calculated 
for each study participant. The METs variable was divided into sex-specific tertiles, and 
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a dichotomous variable was created distinguishing individuals in the lower tertile ("low 
physical activity") from those in the upper two tertiles. 
We carried all the analysis separately for the two population strata (H and NHW) 
because the two exposures distributions were significantly heterogeneous. We first 
evaluated the observed main effect of each exposure using conditional logistic 
regression applied on discordant sib pairs for the T2D affection status. The numbers of 
available subjects were 198 H and 116 NHW for obesity and 458 H and 309 NHW for 
physical inactivity. Exposure frequency was measured in the control samples 
(unaffected sibs) and used as an estimate of exposure prevalence in population. 
For each exposure, we randomly selected one sib for each index in order to 
compute contingency table numbers and global and stratified recurrence risks (KS, KSE 
and KSĒ). The numbers of available pairs were 267 H and 321 NHW for obesity and 246 
H and 268 NHW for physical inactivity. We derived an ORR for each exposure and 
applied the EURECA test of interaction using a logistic regression model. In order to 
account for correlated pairs belonging to the same pedigree, we computed the standard 
error of the logistic regression parameter using a robust sandwich estimator clustered by 
family as implemented in Stata/SE 10.1
16
. When exposure of the random sib was 
available, the pairs were also used to calculate a correlation coefficient between sib 
pairs for each exposure variable using equation 2. 
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Results 
 
Behavior of the Odds Ratio of Recurrence under different disease models 
To evaluate the pertinence of using the ORR as an indicator of the presence of a 
GxE interaction, we investigated the variations of the ORR under different models first 
without correlation between siblings for E (CE = 0). As expected, we observe that, in 
presence of an interaction, the values of the ORR increase with increasing values of the 
interaction coefficient I, but they also depend on the other model parameters. Impacts of 
these parameters are shown in figure 1 for the exposure parameters (fE and RRE) and in 
figure 2 for the genetic parameters (fG and RRG). For a given value of I, ORR is greater 
for high values of fE and RRE (figure 1) and small values of fG. When prevalence of the 
predisposing genotype(s) increases (fG = 0.2), the changes in ORR seen with varying 
RRG tend to disappear and even reverse when interaction values are elevated (figure 2). 
ORR is higher for a dominant as compared to a recessive model at fixed fG. 
Since environmental correlation between sibs might induce a possible confusion 
with a GxE interaction, we looked into variations of ORR values for different values of 
CE, when I = 1 and I = 5 (figure 3). We observe that under the null hypothesis (I = 1), 
the ORR value (referred to as ORR0) is always equal to 1 in situations where there is no 
correlation of the E factor (CE = 0) or when there is no effect of E (RRE = 1). On the 
other hand, in the presence of an effect of E (i.e., RRE  1) associated with a correlation 
between sibs for this factor (i.e., CE  0), the ORR0 values are inflated. In presence of a 
sibling correlation for E, the estimates obtained with a GxE interaction (I = 5, in figure 
3) should thus be tested against the value of ORR0 rather than against 1. The null 
hypothesis of the test becomes "ORR = ORR0". The value of ORR0 depends on the 
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disease prevalence, on the environmental parameters and to a lesser extent on the 
genetic parameters. In order to estimate ORR0, we thus need to obtain some estimates 
these different parameters. Disease prevalence is often known from previous studies in 
similar populations. The environmental parameters (CE, fE, RRE) can be estimated using 
the studied sample when data on the environmental exposure of siblings is available 
(see the type-2 diabetes example here). If this is not the case, results from previous 
studies on the effect of the environmental could be used. Only the genetic model is not 
known. We propose to calculate ORR0 for different genetic model parameters (fG, RRG) 
and then to use as ORR0 the value the closest to the observed ORR. This "worst case 
scenario" ensures a robust inference on the test (see example in the section Results, 
Application to type 2 diabetes). In order to compute the expected ORR0, the Maple 
source code of "EURECA" is available from the corresponding author upon request. 
More theoretical derivation of the ORR0 computation is also given in the Supplementary 
materials.  
 
Properties of the Exposed versus Unexposed Recurrence Analysis test 
In figure 4, the power of the EURECA test of "ORR = ORR0" is reported for 
varying levels of interaction and CE under dominant and recessive models. As expected, 
the power increases with increasing value of I but more interestingly, this increases 
depends on CE and is larger for high CE values than for low CE values. Alternatively, 
table 3 reports the number of sib pairs that are needed to reach a power of 0.80 with a 
type I error rate of 0.05 for increasing values of I and CE under a plausible disease 
model (frequent factors, fG = 0.1 and fE = 0.2; with moderate effects, RRG = 2 and RRE = 
2). In situations with no CE and small I, sample sizes are very high and thus unlikely to 
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be recruited. But considering situations with elevated interaction coefficients (I > 3) and 
with high correlation for exposure in sibs (CE > 0), sample sizes are more reasonable. 
Considering the same frequencies with a sibling correlation of 0.25 and varying 
values of RRE and RRG, the required sample sizes are shown in figure 5. As expected, 
these sizes are smaller when G and E have strong effects, but they seem to be more 
sensitive to G than to E. 
All the previous results considered a disease prevalence (fD) of 0.10. Variations 
in power as a function of interaction and disease prevalence are presented in figure 6. In 
summary, it shows that the best performances of this test are obtained with common 
rather than with rare diseases. When the disease is rare, the sibling recurrence risk (KS) 
is low and the difference between the exposed and unexposed index strata due to the 
GxE interaction is harder to detect. 
 
Application to type 2 diabetes 
The results of the T2D application are presented in table 4. For each population 
strata (H and NHW) and each studied exposure, we show first the environmental 
parameter estimates: ORE (exposure’s odds ratio), fE and CE, and then the proposed GxE 
interaction analysis: ORR and EURECA test. In order to account for CE, we calculated 
the ORR expected under the null hypothesis (ORR0). The Center for Disease Control 
and Prevention (CDC) 2001 diabetes data for the state of Colorado provided diabetes 
prevalence (fD = 4.5 %)
17
. Based on this estimate and using the environmental 
parameters calculated previously on the T2D data, we computed expected ORR0 values 
for a wide range of genetic parameters (fG = 0.01-0.5, RRG =0.5-10). An interval of 
variation of ORR0 was obtained in this way. To ensure robustness of the test, we 
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considered the "worst-case scenario" and compared the observed ORR to the value of 
ORR0 that was the closest to the observed ORR. 
In H, obesity has an ORR equal to 0.67 (95 % CI: 0.40, 1.11). Remarkably in 
this stratum, obesity has a strong significant observed effect of 2.48 (95 % CI: 1.18, 
5.22), which, associated with a CE of 0.22 and a fE of 0.29, gives an expected ORR0 
varying between 1.25 and 1.27. In this example, we used 1.25 (closest value to the 
observed ORR of 0.67) to perform the EURECA test and obtained a p-value of 0.045. In 
NHW, obesity has also a significant observed effect with an OR of 3.87 (95 % CI: 1.54, 
9.65) but the interaction test is not significant. 
Considering physical inactivity, the interaction test is significant in the NHW 
sample only (p = 0.028) and the ORR is 2.13 (95 % CI: 1.08, 4.19). This exposure has 
no significant observed effect and does not aggregate in sib-pairs, which is a situation 
where the proposed test usually lacks power to detect the GxE interaction (as shown in 
table 3 and figure 5). 
Since the sex distributions of indexes and of sibs were homogenous between the 
groups of exposed and unexposed indexes, this variable should not interfere with the 
EURECA test. 
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Discussion 
Contrasting the sibling recurrence risks based on the exposure status of the index 
is a simple and attractive approach to select environmental factors involved in a GxE 
interaction. We propose to measure this contrast by computing an Odds Ratio of 
Recurrence (ORR) and show that the ORR is a good indicator of a GxE interaction. This 
ORR is not a direct measure of interaction but rather a measure of the difference 
between recurrence risks in exposed and unexposed indexes. For example, using the 
low physical activity in NHW result in table 4, the risk of T2D in a NHW individual is 
multiplied on average by a factor of 2.13 when his affected index sib has a low physical 
activity compared to an individual whose affected index sib has a high physical activity. 
At this level of information, discriminating between an underlying genetic component 
interacting with the exposure and the familial clustering of this exposure associated to 
the disease is quite difficult
18
, but our results show that it is possible, provided that the 
effect and familial correlation of the environmental factor is well documented. 
In the context of a dichotomous environmental variable, the interests of using the 
ORR, instead of the ratio of recurrence risks, resides in applying a logistic regression as 
done in most epidemiologic studies, but the same approach can be easily extended to 
multiclass or continuous environmental factors using the classic general linear models. 
The use of continuous variables when available would probably increase the power but 
would also make the assumption of a linear relation. To test for the difference of the 
ORR with a null hypothesis value (ORR0), we derive a statistical test, the Exposed 
versus Unexposed Recurrence Analysis (EURECA) test. To use this test, we need to 
define the value of ORR0. We have derived analytically a formula to compute ORR0 
based on exposure parameter and disease prevalence estimates. These estimates are 
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often easily obtained from the data sample and from the literature. To ensure robustness 
of the test, we suggest accounting for the impact on ORR0 of possible variations in these 
estimates by deriving a range of variation of ORR0 and to consider in the test the ORR0 
value the closest to the observed ORR. Note that the loss of power due to the uncertainty 
of the genetic parameters should be minimal since the ORR0 variations would usually be 
small as in the illustrative example (from 0.01 to 0.03). Interestingly in our example, we 
found even under this "worst-case scenario", it is possible to show that observed ORR 
for some exposure significantly differs from ORR0. This is in good agreement with the 
results of Khoury et al.
10
 showing that the degree of familial aggregation of most 
common diseases cannot be entirely explained by a familial clustering of environmental 
risk factors even if we assume an extreme clustering of the environmental factor. 
The study of the statistical properties of EURECA has shown that the test is 
appropriate to test for common diseases rather than rare ones (figure 6). Interestingly, 
even when the tests are corrected for the exposure correlation in siblings, powers were 
found to be higher for elevated values than for lower values of CE. We hypothesize that 
the sibling correlation actually has a confounding effect on one part, but also 
emphasizes the existing difference in recurrence risks between strata of indexes due to 
the GxE interaction. We only tested positive correlation coefficients between siblings 
for exposure since it is probably the most common situation in familial studies. 
GxE interactions are difficult to detect and often require very large sample sizes. 
In an effort to increase the power to detect GxE interaction, new methods have been 
developed that are based on particular sampling designs. Among these methods are the 
log-linear modeling method that uses case-parent trio data and compares genotype 
distribution of exposed and unexposed cases conditional on parental genotypes
19
, 
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methods that use counter-matching designs to enrich the sample with rare exposure or 
genetic factors
20
 or case-control-combined designs with both population and familial 
controls
21
. A common feature of all these different methods to detect GxE interactions 
is their need to have a complete knowledge of the exposure statuses and genotypes of 
the studied subjects. Among the methods that use familial aggregation of the disease as 
a surrogate for the latent genetic factor, Purcell
7
 proposed to apply variance components 
models in twin studies to evidence GxE interactions with an environmental factor 
measured in both twins. What distinguishes the method we propose here is the type of 
information used in order to assess the GxE interaction. This method relies on the 
exposure of the index case and information on the familial recurrence of the disease. 
There is no need to have a measure of exposure in the sibs and for easily recognizable 
diseases, their affection status might be obtained from indexes. Large sample sizes can 
thus be obtained at a minimal cost. It is true however that if sibs could also be 
examined, familial recurrence will certainly be better estimated. It will also be possible 
to assess, directly from the data rather than from the literature, potential environmental 
correlation between sibs.  
The use of the sib recurrence information as surrogate for genetic risk factors has 
the advantage of requiring no a priori hypothesis on the genetic model underlying 
disease susceptibility. It also permits to test for the involvement in the disease of genetic 
factors located anywhere on the genome at no cost in terms of multiple testing. This is 
an important point as the issue of multiple testing in GxE interaction studies considering 
thousands of genetic markers coupled with tens of exposures remains to be resolved. On 
the counterpart, this approach only stipulates a specific environmental factor and tests 
for its interaction with the genetic component implicated in disease risk increase. As 
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compared to other methods that use both genotypic and environmental information, this 
method could lack power to detect some interaction with a specified genetic factor. But 
it provides an easy way to screen for environmental factors potentially implicated in 
GxE interactions when genotypes are not available. 
Association between T2D and obesity was significant both in H and NHW, as 
previously evidenced in many cross-sectional and longitudinal studies
22
. Concerning 
interaction, EURECA was significant only in H (p = 0.045) with a particular model of 
interaction where the interaction effect is in opposite direction compared to the main 
exposure effect. In an earlier study of recurrence risk estimation in T2D families, 
analogous results were found and elevated recurrence risk ratios were found in siblings 
of non-obese as compared to obese patients
23
. This kind of interaction illustrates the 
situations where the GxE interaction is a nuisance element that has to be accounted for 
in order to better detect a main effect
5,6
. Regarding, low physical activity which had no 
significant observed effect in any of the two populations, the interaction test was 
significant in NHW (p = 0.028) but not in H. A previous study that applied family-based 
association tests and generalized estimating equations models showed a GxE interaction 
between the peroxisome proliferator-activated receptor γ gene and low physical activity 
in H too
13
. Ascertainment of indexes through multiplex families as in the case of the 
GENI study could make it difficult to extrapolate results to the general population of 
diabetic patients. Indeed, an enrichment in disease susceptibility alleles is expected in 
these families and thus sibling recurrence risk estimates are likely to be increased as 
compared to those expected in the general population
23
. However, it should not create 
an erroneous heterogeneity between exposed and unexposed indexes strata unless there 
is a correlation between sibs for the environmental factor that is not correctly accounted 
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for. In this example, the results are likely to encourage further studies to select non 
obese subjects in H populations, in order to search for genetic factors implicated in 
T2D, whereas studying NHW populations, we would be more interested in searching 
for an interaction with low physical activity. This illustrates how one can use the ORR 
point estimates, their confidence intervals and corresponding p-values to rank among 
many environmental factors those that should be selected in priority to test for a GxE 
interaction in following genetic studies. 
In conclusion, this paper demonstrates that valuable amount of familial 
information can be exploited towards detecting GxE interactions that underpin 
multifactorial disease susceptibility. This method is proposed as a strategy that can be 
used prior to genetic studies to help plan these studies. It can help investigators identify 
environmental factors liable to interact with genetic factors and that will need to be 
accounted for in the analysis but could also be used in the study design to select 
subcategories of the population to enhance genetic factor detection. 
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Table 1 Distribution of the sample of sib pairs in cross table according to 
exposure of sib 1 and disease status of sib 2. 
The sibling recurrence risk over the whole sample (KS) and sibling recurrence risks 
stratified on sib 1’s exposure (KSE and KSĒ) can be derived from the observed numbers 
(a, b, c and d). The Odds Ratio of Recurrence (ORR) is equal to: 
 
 
  bc
ad
KK
KK
ORR
SEES
ESSE




1
1
 
 
Sib 1 (affected) 
 
exposed unexposed 
Sib 2 
affected a b a+b 
unaffected c d c+d 
 
a+c b+d N 
KSE = a/(a+c) KSĒ = b/(b+d)  KS = (a+b)/N 
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Table 2 Probability of disease given exposure and genotype statuses according to 
genetic and environmental model parameters. 
 
 
Genotype 
 G– 
(1–fG) 
G+ 
(fG) 
Exposure 
E– 
(1–fE) 
B B.RRG 
E+ 
(fE) 
B.RRE B.RRG.RRE.I 
 
E+: exposed; E–: unexposed; fE: proportion of exposed individuals in population; G+: 
carrier of the predisposing genotype(s); G–: non-carrier of the predisposing genotype(s); 
fG: proportion of carriers of the predisposing genotype(s) in population; B: baseline risk; 
RRE: exposure relative risk; RRG: genotypic relative risk; I: multiplicative interaction 
coefficient for individuals both exposed and carrier of the predisposing genotype. 
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Table 3 Sample size (number of sib pairs) required to obtain a power of 0.80 with 
a type I error rate of 0.05 as a function of the interaction coefficient (I) and the 
environmental correlation between sibs (CE). 
Fixed parameters: disease prevalence: fD = 0.1; frequency of predisposing genotype(s): 
fG = 0.1; genotypic relative risk: RRG = 2; frequency of exposure: fE = 0.2; exposure 
relative risk: RRE = 2. 
 Recessive model Dominant model 
I 1 2 3 5 10 1 2 3 5 10 
CE 
0 ∞ 72 417 13 885 2946 720 ∞ 41 516 8061 1754 448 
0.25 ∞ 12 250 2568 619 181 ∞ 8418 1745 423 126 
0.5 ∞ 5371 1182 307 99 ∞ 3875 841 219 70 
0.75 ∞ 3172 725 199 67 ∞ 2345 529 145 47 
1 ∞ 2163 511 147 51 ∞ 1625 379 108 35 
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Table 4 Results of the application on type 2 diabetes data. 
Environmental factor Obesity Low physical activity 
Stratum H NHW H NHW 
ORE 2.48 3.87 1.13 0.93 
95 % CI of ORE 1.18, 5.22 1.54, 9.65 0.72, 1.77 0.53, 1.65 
fE 0.29 0.37 0.31 0.23 
CE  0.22 0.14 – 0.02 0.07 
ORR0 1.25*, 1.27 1.22*, 1.25 0.99, 1.00* 0.99, 1.00* 
ORR 0.67 1.03 1.14 2.13 
95 % CI of ORR 0.40, 1.11 0.53, 1.99 0.62, 2.08 1.08, 4.19 
EURECA 4.03 0.25 0.15 4.78 
p-value 0.045 0.617 0.70 0.028 
H: Hispanics; NHW: Non-Hispanic Whites; ORE: Odds Ratio estimate of the 
environmental factor; fE: Estimated frequency of the environmental factor; CE: 
Estimated sibling correlation for the environmental factor; ORR0: Interval of variation 
of the expected Odds Ratio of Recurrence under the null hypothesis; * Closest bounding 
value used to perform the test; ORR: Odds Ratio of Recurrence; CI: confidence interval; 
EURECA: Exposed versus Unexposed Recurrence Analysis. 
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Figure 1 Odds Ratio of Recurrence (ORR) as a function of the gene-environment 
interaction coefficient (I) for varying exposure prevalences (fE), varying exposure 
relative risks (RRE) and for a recessive and a dominant genetic model. 
 
Fixed parameters: disease prevalence: fD = 0.1; frequency of predisposing genotype(s): 
fG = 0.1; genotypic relative risk: RRG = 1; sibling correlation for the environmental 
factor: CE = 0. 
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Figure 2 Odds recurrence ratio (ORR) as a function of the gene-environment 
interaction coefficient (I) for varying frequencies of predisposing genotype(s) (fG), 
varying genotypic relative risks (RRG) and for a recessive and a dominant genetic 
model. 
 
Fixed parameters: disease prevalence: fD = 0.1; frequency of exposure: fE = 0.2; 
exposure relative risk: RRE = 1; sibling correlation for the environmental factor: CE = 0. 
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Figure 3 Odds Ratio of Recurrence (ORR) as a function of the sibling correlation 
for the environmental factor (CE) and the environmental factor relative risk (RRE). 
 
Fixed parameters: disease prevalence: fD = 0.1; frequency of exposure: fE = 0.2; 
frequency of predisposing genotype(s): fG = 0.1; genotypic relative risk: RRG = 1. 
Solid curves represent null hypothesis scenarios and dotted curves represent 
corresponding situations with a gene-environment interaction (I) of 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
Figure 4 Power of the EURECA test as a function of the interaction coefficient I 
and the sibling correlation for exposure CE, after accounting for inflated type I error 
rates due to CE, considering a sample size of 1000 sib-pairs. 
 
Fixed parameters: disease prevalence: fD = 0.1; frequency of exposure: fE = 0.2; 
exposure relative risk: RRE = 2; frequency of predisposing genotype(s): fG = 0.1; 
genotypic relative risk: RRG = 2. 
Dotted curves represent computations for recessive models and solid curves for 
dominant models. 
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Figure 5 Required sample size (number of sib pairs) to obtain a power of 0.80 
with a type I error rate of 0.05 as a function of the interaction coefficient (I) for different 
exposure (RRE) and genotypic (RRG) relative risks. 
 
Fixed parameters: disease prevalence: fD = 0.1; frequency of exposure: fE = 0.2; 
frequency of predisposing genotype(s): fG = 0.1; sibling correlation for the 
environmental factor: CE = 0.25. 
Dotted curves represent computations for recessive models and solid curves for 
dominant models. 
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Figure 6 Power of the EURECA test as a function of the interaction coefficient I 
and the disease prevalence fD, after accounting for inflated type I error rates due to CE, 
considering a sample size of 1000 sib-pairs. 
 
Fixed parameters: frequency of exposure: fE = 0.2; exposure relative risk: RRE = 2; 
frequency of predisposing genotype(s): fG = 0.1; genotypic relative risk: RRG = 2; 
sibling correlation for the environmental factor: CE = 0.25. 
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Supplementary materials 
 
Computation of contingency table’s observed number given model parameters 
 
An individual can have one of three possible genotypes (for a biallelic genetic 
locus) and one of two exposure statuses (for a dichotomous environmental variable). 
Thus any two siblings may have 36 (6 × 6) possible combinations of genotypes and 
exposure statuses whose joint probabilities can be obtained by modifying the ITO 
matrix method of Li and Sacks
12
 to account for exposure probabilities (table S1). In 
table S2 are shown probabilities for an individual to be affected or unaffected given his 
genotype and his exposure status, expressed according to model parameters.  
We first calculate joint probabilities of having an exposed (or unexposed) 
mandatorily affected sib 1 and an affected (or unaffected) sib 2 used to calculate 
contingency table 1 numbers. The indices "i" and "j" refer to the cells of the Uij matrix 
presented in table S1: 
Pa = P(sib 1 D+ E+ and sib 2 D+) =  
 

3
1
6
1
)()(
i j
ij
jDPiDPU   (3) 
Pb = P(sib 1 D+ E– and sib 2 D+) = 
 

6
4
6
1
)()(
i j
ij
jDPiDPU   (4) 
Pc = P(sib 1 D+ E+ and sib 2 D–) = 
 

3
1
6
1
)()(
i j
ij
jDPiDPU   (5) 
Pd = P(sib 1 D+ E– and sib 2 D–) = 
 

6
4
6
1
)()(
i j
ij
jDPiDPU   (6) 
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where D+ is the event of being affected with disease D and E+ is the event being 
exposed to environmental factor E, "i" represents possible genotype-exposure 
combinations for sib 1 and "j" possible genotype-exposure combinations for sib 2. 
Their sum is equal to the a priori probability of disease in sib 1: 
Ptotal = P(sib 1 D+) = Pa + Pb + Pc + Pd      (7) 
Finally, using equations 3 to 7, we determine contingency table 1 observed numbers: 
a = N × Pa / Ptotal 
b = N × Pb / Ptotal 
c = N × Pc / Ptotal 
d = N × Pd / Ptotal 
where N is the total number of sib-pairs. 
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Computation of ORR0: 
The ORR0 formula derive from the ORR considering a model with no interaction (I = 1). 
It is a difficult formula to write on a single page since it depends on 6 parameters: the 
susceptibility genotype(s) frequency (fG) and relative risk (RRG), the environmental 
factor frequency (fE) and relative risk (RRE), the environmental correlation between sibs 
(CE) and the disease prevalence in population (fD). But according to the type 2 diabetes 
application results, the ORR0 seems to depend predominantly on the environmental 
parameters (fE, RRE, and CE) and on the disease prevalence (fD) and to a lesser extent on 
the genetic parameters. 
 
Considering no effect of the genetic factor (RRG = 1), the ORR0 can be expressed as: 
     
   
    
       11111
1111
111
1111
0






DEDEEEED
DEDEE
EEE
EEEEE
fCfRRfRRCf
fCfRRf
CfRR
CfRRRRC
ORR
 
 
But in order to obtain the expected range of values of ORR0 as presented in table 4, 
computations were done for different values for the genetic model: fG from 0.01 to 0.5 
and RRG ranging from 0.5 to 10. 
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Table S1    Sib-sib joint probabilities matrix Uij for genotypic and exposure distributions modified from the ITO matrix method of Li and Sacks
12
. 
 
Sib 1 
Total E1+ E1– 
AA 
i = 1 
Aa 
i = 2 
aa 
i = 3 
AA 
i = 4 
Aa 
i = 5 
aa 
i = 6 
Sib 2 
E2+ 
AA 
j = 1 
 22 141 qq   


1/21 EEE
ff  
 22 121 qq   


1/21 EEE
ff  
 22 141 qq   


1/21 EEE
ff  
 22 141 qq   


1/21 EEE
ff  
 22 121 qq   


1/21 EEE
ff  
 22 141 qq   


1/21 EEE
ff  2
2
E
fq  
Aa 
j = 2 
 22 121 qq   


1/21 EEE
ff  
    qqqq  111  


1/21 EEE
ff  
   qqq  2121
2  


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ff  
 22 121 qq   


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ff  
    qqqq  111  


1/21 EEE
ff  
   qqq  2121
2  


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ff  
 


2
12
E
fqq  
aa 
j = 3 
 22 141 qq   


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 


2
2
1
E
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AA 
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 22 141 qq   

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
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
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
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
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
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2
E
fq  
Aa 
j = 5 
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

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
1/21 EEE
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

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

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
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ff  
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

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 22 141 qq   


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   qqq  2121
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

1/21 EEE
ff  
 


2
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E
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Total (ωi) 1
2
E
fq     112 Efqq     1
2
1
E
fq  1
2
E
fq     112 Efqq     1
2
1
E
fq  1 
A: allele that confers susceptibility to disease; E1X: exposure status of sib 1 (X = + if exposed and X = – if unexposed); E2Y: exposure 
status of sib 2 (Y = + if exposed and Y = – if unexposed); q: frequency of allele A in population; fE1X: frequency of exposed status X in sib 1 
(equal to the same frequencies as in population); fE2Y/E1X: frequency of exposed status Y in sib 2 given exposure status X of sib 1 (equal to 
same frequencies as in population if exposure correlation coefficient for sib-pairs is null, CE = 0). 
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Table S2 Probabilities for an individual to be affected (P (D+ | k)) or unaffected 
(P (D– | k)) for the six possible combinations of genotype and exposure statuses. 
 
 
E+ E– 
AA 
k = 1 
Aa 
k = 2 
aa 
k = 3 
AA 
k = 4 
Aa 
k = 5 
aa 
k = 6 
P (D+ | k) PEG 
PE
1
 
PEG
2
 
PE PG 
PB
1
 
PG
2
 
PB 
P (D– | k) 
1–PEG 
1–PE
1
 
1–PEG
2
 
1–PE 1–PG 
1–PB
1
 
1–PG
2
 
1–PB 
1
 if autosomal recessive transmission 
2
 if autosomal dominant transmission 
A: allele that confers susceptibility to disease; E+: exposed; E–: unexposed; B: baseline 
risk; RRE: exposure relative risk; RRG: genotypic relative risk; I: Interaction coefficient; 
PB: probability of disease in non-exposed and non-carrier of susceptibility genotype 
individual (PB = B); PE: probability of disease in exposed and non-carrier of 
susceptibility genotype individual (PE = B × RRE); PG: probability of disease in non-
exposed and carrier of susceptibility genotype individual (PG = B × RRG); PEG: 
probability of disease in exposed and carrier of susceptibility genotype individual 
(PEG = B × RRE × RRG × I). 
 
